Company

Invengene Recognised as a Great Place To Work®, Reflecting a Strong People-First Culture

September 22, 2025
Invengene Recognised as a Great Place To Work®, Reflecting a Strong People-First Culture
Invengene is proud to be Certified™ by Great Place To Work for 2025–26. This recognition is based entirely on feedback from Invengene’s employees, reflecting their experience across trust, culture, and workplace practices. This year, 100% of employees said Invengene is a great place to work.

Great Place To Work® is the global authority on workplace culture, employee experience, and leadership behaviours proven to drive sustainable business performance, talent retention, and innovation.

“At Great Place To Work®, we believe that a strong workplace culture is built on trust, purpose, and a people-first approach. By earning this Certification, Invengene has demonstrated a clear commitment to creating an environment where people feel valued, empowered, and able to do their best work. This recognition reflects the collective effort of the organisation in building a culture that supports growth and excellence,” said Balbir Singh, CEO, Great Place To Work®, India.

Commenting on the achievement, Ankur Shah, Chairman & Managing Director, Invengene, said,
“Being Great Place To Work® Certified is meaningful for us because it reflects what our people experience every day. At Invengene, we are building a science-led, partnership-driven organisation, and that requires a culture rooted in trust, ownership, and respect. This recognition belongs to our teams who consistently raise the bar in how we collaborate, innovate, and grow together.”

Invengene’s workplace culture is shaped by a strong emphasis on accountability, cross-functional collaboration, and continuous learning. Over the past year, the company has strengthened employee engagement through transparent leadership communication, structured feedback mechanisms, and people-centric initiatives focused on well-being, professional growth, and inclusive decision-making. These efforts support Invengene’s ability to execute complex pharmaceutical programs while maintaining a close connection between individual contributions and real-world patient impact.